Caladrius Biosciences, Inc. (LSTA) Tops Q3 EPS by 16c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q3 EPS of ($0.59), $0.16 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Amer Sports Inc. (AS) PT Lowered to $42 at Truist, but 'Momentum continues to surge in a tough macro'
• Lowe's slashes full-year sales outlook amid DIY spending pressure
• UBS Reiterates Buy Rating on Gap, Inc. (GAP), Says Earnings Could Be a High-Volatility Event